Long-Term Outcomes in HBV Patients with Hepatitis B Surface Antigen Seroclearance

A meta-analysis supports use of seroclearance as a surrogate endpoint for improved clinical outcomes in patients with chronic HBV infection.

Source link

Related posts

HCV p7 as a novel vaccine-target inducing multifunctional CD4+ and CD8+ T-cells targeting liver cells expressing the viral antigen


The magnitude and correlates of esophageal Varices among newly diagnosed cirrhotic patients undergoing screening fibre optic endoscope before incident bleeding in North-Western Tanzania; a cross-sectional study


Excessive Drinking Seen in Some Patients With Chronic Conditions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World